Martin Possienke
Martin Possienke
bad certainly given high percent portfolio positive product target
The buyback is certainly a positive for the shares, and the profitability target of 20 percent is not bad given that Schering's product portfolio does not have many new drugs with high margins.
christmas expected liquid outlook recovery season shows
It shows the expected recovery in the Christmas season in liquid crystals. But the outlook is a little disappointing.